88. Converging Therapies: Clinical Insights on the Mechanistic Crossroads of Lamotrigine and Therapeutic Ketosis in Bipolar Disorder
Dina N. Ali(WinnMed), Mark A. Frye(Mayo Clinic), Allie Anderson(WinnMed), Mete Ercis(Mayo Clinic), Matej Markota(WinnMed), Vanessa Pazdernik(Mayo Clinic in Florida), Jonathan G. Leung(WinnMed), Ayşegül Özerdem(Universidade Federal do Rio Grande do Sul), Iain H. Campbell(Royal Edinburgh Hospital), Duan Liu(WinnMed), Kyla Lara-Breitinger(WinnMed), Tamahara Gonzalez‐Campos(WinnMed), Stacey J. Winham(Mayo Clinic)
Cited by 1
Related Papers
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754
Global Disease Burden Estimates of Respiratory Syncytial Virus–Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis
|The Journal of Infectious Diseases|2019|534
Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis
|Journal of Affective Disorders|2022|208
Patterns of pharmacotherapy for bipolar disorder: A <scp>GBC</scp> survey
|Bipolar Disorders|2023|76
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis
|Molecular Psychiatry|2022|71